Puma Biotechnology Inc (PBYI)
2.985
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 14, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Shareholders Equity (Quarterly): 71.09M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 71.09M |
June 30, 2024 | 48.51M |
March 31, 2024 | 50.98M |
December 31, 2023 | 53.44M |
September 30, 2023 | 38.74M |
June 30, 2023 | 30.40M |
March 31, 2023 | 25.85M |
December 31, 2022 | 21.61M |
September 30, 2022 | 22.16M |
June 30, 2022 | 19.74M |
March 31, 2022 | 7.145M |
December 31, 2021 | -2.446M |
September 30, 2021 | -10.92M |
June 30, 2021 | 29.47M |
March 31, 2021 | 16.44M |
December 31, 2020 | -5.951M |
September 30, 2020 | -0.453M |
June 30, 2020 | 23.40M |
March 31, 2020 | 9.377M |
December 31, 2019 | 17.46M |
September 30, 2019 | 17.18M |
June 30, 2019 | 21.77M |
March 31, 2019 | 43.47M |
December 31, 2018 | 34.31M |
September 30, 2018 | 45.91M |
Date | Value |
---|---|
June 30, 2018 | 38.30M |
March 31, 2018 | 57.46M |
December 31, 2017 | 53.30M |
September 30, 2017 | 79.17M |
June 30, 2017 | 120.11M |
March 31, 2017 | 167.39M |
December 31, 2016 | 209.82M |
September 30, 2016 | 91.15M |
June 30, 2016 | 127.08M |
March 31, 2016 | 164.94M |
December 31, 2015 | 206.01M |
September 30, 2015 | 244.84M |
June 30, 2015 | 274.78M |
March 31, 2015 | 304.34M |
December 31, 2014 | 117.05M |
September 30, 2014 | 141.60M |
June 30, 2014 | 167.04M |
March 31, 2014 | 198.79M |
December 31, 2013 | 83.99M |
September 30, 2013 | 94.76M |
June 30, 2013 | 107.02M |
March 31, 2013 | 118.28M |
December 31, 2012 | 128.91M |
September 30, 2012 | 9.002M |
June 30, 2012 | 28.04M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.92M
Minimum
Sep 2021
71.09M
Maximum
Sep 2024
23.30M
Average
21.88M
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.29B |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 220.72M |
Total Liabilities (Quarterly) | 149.63M |
Debt to Equity Ratio | 1.098 |
Current Ratio | 1.420 |
Net Debt Paydown Yield | 3.34% |